Cardiorenal syndrome: new developments in the understanding and pharmacologic management.
about
NT-proBNP and troponin T and risk of rapid kidney function decline and incident CKD in elderly adults.Peripheral Edema, Central Venous Pressure, and Risk of AKI in Critical Illness.The cytohesin guanosine exchange factors (GEFs) are required to promote HGF-mediated renal recovery after acute kidney injury (AKI) in mice.Cardiorenal syndrome: introduction.Echocardiographic Measures and Estimated GFR Decline Among African Americans: The Jackson Heart Study.Increased susceptibility to structural acute kidney injury in a mouse model of presymptomatic cardiomyopathy.Renal function decline predicted by left atrial expansion index in non-diabetic cohort with preserved systolic heart function.
P2860
Q35051193-F3B0C90C-916E-45DE-B5F3-1CE75488D466Q36770897-8F7CD845-0BF8-4963-BA11-76E3EFEB93FEQ42038856-5429F96B-7F4F-4598-97DC-A67B9D383D9CQ42959036-84385542-BFB7-436C-8B18-E0B54C35324DQ47980746-6122E909-D7CF-43D9-855E-6B5B407B492FQ50544634-50485BE0-0E2A-48A8-9684-5BD07C11AB45Q50964328-21B18F15-45B1-4D88-BEB5-F61B6E28E5A8
P2860
Cardiorenal syndrome: new developments in the understanding and pharmacologic management.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cardiorenal syndrome: new developments in the understanding and pharmacologic management.
@en
type
label
Cardiorenal syndrome: new developments in the understanding and pharmacologic management.
@en
prefLabel
Cardiorenal syndrome: new developments in the understanding and pharmacologic management.
@en
P2860
P356
P1476
Cardiorenal syndrome: new developments in the understanding and pharmacologic management.
@en
P2093
Andrew A House
P2860
P304
P356
10.2215/CJN.02920313
P577
2013-08-08T00:00:00Z